What Fueled The Previous Growth In The Single-Chamber Prefilled Syringes Market?
The single-chamber prefilled syringes market has seen considerable growth due to a variety of factors.
• In recent times, the market size for single-chamber prefilled syringes has seen a swift expansion. The market is projected to rise from $10.72 billion in 2024 to $12.03 billion in 2025, with a compound annual growth rate (CAGR) of 12.2%.
Factors such as advancements in the pharmaceutical and biotechnology sectors, increased demand for patient-friendly drug administration, the convenience and safety provided, the need for accurate drug dosage, and regulatory approvals and guidelines have all contributed to the significant growth in the historic period.
What Is The Expected Growth In The Single-Chamber Prefilled Syringes Market Size?
The single-chamber prefilled syringes market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for rapid expansion in the single-chamber prefilled syringes market in the coming years. It is predicted to rise to $22.44 billion in 2029, with an impressive compound annual growth rate (CAGR) of 16.9%.
This projected growth in the forecast period is attributed to several factors, including the use of biologics and biosimilars in prefilled syringes, self-administration and home healthcare, drug delivery for pediatric and geriatric patients, combo products with auto-injectors, regulatory emphasis on drug safety, and the rise of telemedicine and remote monitoring. The forecast period also spots significant trends such as prefilled syringes incorporated with connected devices, eco-friendly and biodegradable materials, personalized syringe options, safety features to prevent needlestick injuries, prefilled syringes designed for cell and gene therapies, and prefilled syringes enhanced with anti-counterfeiting measures.
What Are The Leading Drivers Of Growth In The Single-Chamber Prefilled Syringes Market?
The rise in chronic illnesses like diabetes and cancer is fueling the expansion of the single-chamber prefilled syringe market. The single-chamber prefilled syringe is employed by diabetic patients needing insulin therapy when medications do not manage their blood sugar levels adequately. For instance, as per the World Health Organization, a Switzerland-based agency tasked with global public health, there are predictions of over 35 million fresh cancer cases by 2050, signifying a 77% upsurge from the estimated 20 million cases in 2022. Consequently, the escalating prevalence of chronic illnesses such as diabetes and cancer is propelling the single-chamber prefilled syringe market.
How Are The Segments Defined Within The Global Single-Chamber Prefilled Syringes Market?
The single-chamber prefilled syringes market covered in this report is segmented –
1) By Type: Glass, Plastic
2) By Application: Vaccine Product, Biologic, Pharmaceutical Product
Subsegments:
1) By Glass: Borosilicate Glass Syringes, Type I Glass Syringes, Type II Glass Syringes
2) By Plastic: Polypropylene Syringes, Polycarbonate Syringes, Cyclo-olefin Polymer Syringes
Pre-Book The Single-Chamber Prefilled Syringes Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Expected To Influence The Growth Of The Single-Chamber Prefilled Syringes Market?
The single-chamber prefilled syringe market is evolving due to the growth in technological innovations. Key players in this sector are focusing on the creation of technology-centric solutions to solidify their market presence. For instance, Otsuka America Pharmaceutical, Inc., a healthcare company from the US, and H. Lundbeck A/S, an international pharmaceutical firm from Denmark, launched Aripiprazole 2-month in September 2022. This product, presented in a single-chamber, prefilled syringe, offers a two-month, ready-to-use, a long-acting injectable version of aripiprazole. The injection is intended to be applied intramuscularly into the gluteal muscle every two months as per the prescribed dosage.
Who Are the Key Players in the Single-Chamber Prefilled Syringes Market?
Major companies operating in the single-chamber prefilled syringes market include:
• Becton
• Dickinson and Company
• Gerresheimer Glass Inc.
• Schott AG
• Catalent Inc.
• Nipro Medical Corporation
• Weigao Group Medical Polymer Company Limited
• Stevanato Group S.p.A.
• Baxter International Inc.
• Vetter Pharma International GmbH
• Terumo Corporation
• Ypsomed Holding AG
• SHL Medical AG
• Ompi
• Elcam Medical A.C.S. Ltd.
• Oval Medical Technologies Ltd.
• West Pharmaceutical Services Inc.
• Gerresheimer Regensburg GmbH
• SCHOTT North America Inc.
• Vetter Pharma-Fertigung GmbH & Co. KG
• Aptar Pharma Services Inc.
• Bespak Europe Ltd.
• Credence MedSystems Inc.
• Datwyler Pharma Packaging International Holding AG
• Dätwyler Sealing Solutions AG
• Fresenius Kabi AG
• Haselmeier GmbH
• Hikma Pharmaceuticals PLC
• HTL-STREFA S.A.
• Intas Pharmaceuticals Ltd.
What Is The Most Dominant Region In The Single-Chamber Prefilled Syringes Market?
North America was the largest region in the single-chamber prefilled syringes market in 2024. Asia-Pacific was the second largest region in the single-chamber prefilled syringes market share. The regions covered in the single-chamber prefilled syringes market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
